4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine

C36H52BClN8O4 — CID 160819198

IUPAC4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine
SMILESCC1COCCN1CCCn1cc(-c2cnc3ccc(Cl)nc3c2)cn1.CC1COCCN1CCCn1cc(B2OC(C)(C)C(C)(C)O2)cn1
InChIInChI=1S/C19H22ClN5O.C17H30BN3O3/c1-14-13-26-8-7-24(14)5-2-6-25-12-16(11-22-25)15-9-18-17(21-10-15)3-4-19(20)23-18;1-14-13-22-10-9-20(14)7-6-8-21-12-15(11-19-21)18-23-16(2,3)17(4,5)24-18/h3-4,9-12,14H,2,5-8,13H2,1H3;11-12,14H,6-10,13H2,1-5H3
InChIKeySFHRZDHOVYJHLL-UHFFFAOYSA-N
MW707.13 g/mol
LogP4.55
Rot. Bonds10

About 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine

4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine (PubChem CID 160819198) has the molecular formula C36H52BClN8O4 and a molecular weight of 707.13 g/mol. Its IUPAC name is 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine.

Molecular Properties

Compound Name4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine
PubChem CID160819198
Molecular FormulaC36H52BClN8O4
Molecular Weight707.13 g/mol
Exact Mass706.39
IUPAC Name4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine
SMILESCC1COCCN1CCCn1cc(-c2cnc3ccc(Cl)nc3c2)cn1.CC1COCCN1CCCn1cc(B2OC(C)(C)C(C)(C)O2)cn1
InChIInChI=1S/C19H22ClN5O.C17H30BN3O3/c1-14-13-26-8-7-24(14)5-2-6-25-12-16(11-22-25)15-9-18-17(21-10-15)3-4-19(20)23-18;1-14-13-22-10-9-20(14)7-6-8-21-12-15(11-19-21)18-23-16(2,3)17(4,5)24-18/h3-4,9-12,14H,2,5-8,13H2,1H3;11-12,14H,6-10,13H2,1-5H3
InChIKeySFHRZDHOVYJHLL-UHFFFAOYSA-N
XLogP4.55
TPSA104.82 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500707.13
LogP ≤ 54.55
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine?
The IUPAC name of 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine (CID 160819198) is 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine.
What is the SMILES notation for 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine?
The canonical SMILES for 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine is CC1COCCN1CCCn1cc(-c2cnc3ccc(Cl)nc3c2)cn1.CC1COCCN1CCCn1cc(B2OC(C)(C)C(C)(C)O2)cn1.
What is the InChIKey of 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine?
The InChIKey is SFHRZDHOVYJHLL-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H22ClN5O.C17H30BN3O3/c1-14-13-26-8-7-24(14)5-2-6-25-12-16(11-22-25)15-9-18-17(21-10-15)3-4-19(20)23-18;1-14-13-22-10-9-20(14)7-6-8-21-12-15(11-19-21)18-23-16(2,3)17(4,5)24-18/h3-4,9-12,14H,2,5-8,13H2,1H3;11-12,14H,6-10,13H2,1-5H3.
What are the key properties of 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine?
4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine has a molecular weight of 707.13 g/mol, XLogP of 4.55, 10 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)pyrazol-1-yl]propyl]-3-methylmorpholine;3-methyl-4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propyl]morpholine is sourced from PubChem (CID 160819198), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).